Class 4 Drug Alert: Actilyse (alteplase)
Pharmacy Magazine,
1 Min
Class 4 Drug Alert: Actilyse (alteplase)
Pharmacy Magazine,
1 Min
In News
Follow this topic
Bookmark
Record learning outcomes
The MHRA has issued a Class 4 (Caution in Use) Drug Alert for Actilyse 20mg and 50mg powder and solvent for solution for injection and infusion (alteplase).
There have been an increased number of complaints where the rubber stopper has been pushed into the vial during reconstitution. This renders the vial unusable.
Video Player is loading.
Users who experience this issue are asked to report to Boehringer Ingleheim Medical Information on 01344 742579 or medinfo.bra@boehringer-ingelheim.com
Full details are available via the MHRA.
Copy Link
Record my learning outcomes
Save for later
In News
Stay up to date with all the news, learning and insight in the world of pharmacy.